Susquehanna Fundamental Investments, LLC Bluebird Bio, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $1.09 Million - $1.61 Million	189,410 New	189,410 $1.31 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $332,750 - $458,832	-12,100 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $179,088 - $227,500	-5,200 Reduced 30.06%	12,100 $653,000
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $469,176 - $795,281	17,300 New	17,300 $1.06 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.